Tyrosine kinase inhibitors in systemic sclerosis: The case for imatinib

Flavia V. Castelino, Swati Bhattacharyya, John Varga*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)161-163
Number of pages3
JournalCurrent Rheumatology Reports
Issue number3
StatePublished - Jul 1 2009

ASJC Scopus subject areas

  • Rheumatology

Cite this